Results for: Monkeypox

Sweden has confirmed its first case of clade 1 mpox, a more severe strain of the virus previously only seen in Africa. This case, detected in Stockholm, was likely acquired during a trip to an area with an ongoing clade 1 outbreak. The World Health Organization (WHO) recently declared the clade 1 outbreaks in Africa a public health emergency, highlighting the seriousness of this strain. While Sweden’s health agency considers the risk to the general population low, they are closely monitoring the situation and will implement further measures if necessary.

The World Health Organization’s declaration of a public health emergency for the mpox outbreak has sent shockwaves through the healthcare market, causing several stocks associated with the virus to experience significant price fluctuations. While some companies, like Emergent Biosolutions and Bavarian Nordic, saw gains due to their involvement in vaccine production, others like SIGA Technologies faced setbacks after their antiviral treatment failed to meet a key trial endpoint.

Sweden has confirmed its first case of Mpox caused by the Clade I variant, marking the first such case outside of the African continent. This comes a day after the World Health Organization (WHO) declared the increasing spread of Mpox in Africa a global health emergency.

SIGA Technologies’ tecovirimat, marketed as Tpoxx, failed to demonstrate a statistically significant improvement in time to lesion resolution in a preliminary analysis of the PALM 007 trial for monkeypox treatment in the Democratic Republic of Congo. While the drug did not meet its primary endpoint, it showed promise for patients with severe disease or those whose symptoms began within seven days of randomization. The trial also highlighted the importance of supportive care in improving outcomes for monkeypox patients.

The World Health Organization (WHO) has declared mpox a public health emergency of international concern, the highest level of alert, due to a severe outbreak in Congo. The outbreak has seen over 27,000 cases and 1,100 deaths since January 2023, and a new, rapidly spreading strain has raised global concerns.

The World Health Organization (WHO) has declared mpox a public health emergency of international concern due to the rapid spread of the disease in Eastern Democratic Republic of Congo and neighboring countries. The declaration triggers a global response to contain the outbreak and provides resources to affected countries.

A growing mpox outbreak in Africa, primarily in the Democratic Republic of Congo (DRC), has prompted the World Health Organization (WHO) to consider declaring a public health emergency of international concern. The outbreak, featuring a new, more deadly clade of the virus, has spread to neighboring countries and could pose a significant threat globally.

A deadly new strain of mpox, particularly lethal to children and pregnant women, is rapidly spreading in the Democratic Republic of Congo (DRC). This variant, known as clade 1b, has a higher mortality rate than previous strains and is transmitted through both sexual and non-sexual contact. The outbreak has already claimed hundreds of lives, with children under 15 accounting for nearly half of the deaths. While experts are unsure of the likelihood of a global outbreak, they emphasize the need for urgent research, improved access to vaccines and treatments, and increased awareness to prevent further spread.

A virulent strain of the monkeypox virus, clade I, has emerged in the Democratic Republic of the Congo (DRC), exhibiting the ability to spread through sexual contact. This strain is more lethal than those involved in previous outbreaks, including the global spread in 2022. The outbreak poses a significant risk of wider transmission, particularly among sex workers, and has raised concerns among scientists about a possible resurgence similar to the mpox outbreak in 2022. International support is dringendly needed to provide vaccinations and enhance diagnostic capabilities within the DRC.